MedicarePartD.guide

A non-government resource built from CMS public data

Maintenance inhalers for COPD and asthma on every 2026 Connecticut Part D plan

Pick a drug class, or type the drugs you want to check, and see which of the 11 stand-alone Part D plans in Connecticut cover each one, on what tier, and with what restrictions.

A class overrides typed names. Separate names with commas; brand or generic both work.

  • Covered
  • Covered, needs prior authorization (PA) or step therapy (ST)
  • Not on the formulary
  • QL 60/30d = quantity limit, 60 units per 30 days

11 plans, cheapest premium first. Scroll sideways for all of them →

Maintenance inhalers for COPD and asthma by 2026 Connecticut Part D plan
DrugHumana Basic Rx Plan$8.40/moS5884-102Wellcare Value Script$16.40/moS4802-137Blue MedicareRx Value Plus$20.70/moS2893-001Wellcare Classic$21.70/moS4802-076SilverScript Choice$32.70/moS5601-004AARP Medicare Rx Saver from UHC$38.70/moS5921-348Humana Value Rx Plan$73.60/moS5884-182Humana Premier Rx Plan$138.60/moS5884-149HealthSpring Assurance Rx$139.30/moS5617-008AARP Medicare Rx Preferred from UHC$155.10/moS5921-385Blue MedicareRx Premier$238.60/moS2893-003
Trelegy Elliptafluticasone/umeclidinium/vilanterolTier 325%QL 60/30dTier 325%QL 60/30dTier 317%QL 60/30dTier 325%QL 60/30dTier 319%QL 60/30dTier 317%QL 60/30dTier 318%QL 60/30dTier 3$45.00QL 60/30dTier 321%QL 60/30dTier 315%QL 60/30dTier 3$30.00QL 60/30d
Breztri Aerospherebudesonide/glycopyrrolate/formoterolTier 325%QL 10.7/30dTier 325%QL 10.7/30dTier 317%QL 10.7/30dTier 325%QL 10.7/30dTier 319%QL 10.7/30dNot coveredTier 318%QL 10.7/30dTier 3$45.00QL 10.7/30dNot coveredTier 315%QL 10.7/30dTier 3$30.00QL 10.7/30d
Anoro Elliptaumeclidinium/vilanterolNot coveredTier 325%QL 60/30dTier 317%QL 60/30dTier 325%QL 60/30dTier 319%QL 60/30dTier 317%QL 60/30dNot coveredNot coveredTier 321%QL 60/30dTier 315%QL 60/30dTier 3$30.00QL 60/30d
Stiolto Respimattiotropium/olodaterolTier 325%QL 4/28dNot coveredNot coveredNot coveredNot coveredTier 317%QL 4/30dTier 318%QL 4/28dTier 3$45.00QL 4/28dNot coveredTier 315%QL 4/30dNot covered
SpirivatiotropiumTier 325%QL 30/30dTier 440%QL 4/30dTier 432%QL 4/30dTier 429%QL 4/30dTier 435%QL 4/30dTier 317%QL 30/30dTier 318%QL 30/30dTier 3$45.00QL 30/30dTier 4ST31%QL 4/30dTier 315%QL 30/30dTier 435%QL 4/30d
Incruse ElliptaumeclidiniumNot coveredTier 325%QL 30/30dTier 317%QL 30/30dTier 325%QL 30/30dTier 319%QL 30/30dNot coveredNot coveredNot coveredTier 321%QL 30/30dTier 315%QL 30/30dTier 3$30.00QL 30/30d
Breo Elliptafluticasone/vilanterolTier 325%QL 60/30dTier 325%QL 60/30dTier 317%QL 60/30dTier 325%QL 60/30dTier 319%QL 60/30dTier 317%QL 60/30dTier 318%QL 60/30dTier 3$45.00QL 60/30dTier 321%QL 60/30dTier 315%QL 60/30dTier 3$30.00QL 60/30d
Symbicortbudesonide/formoterolTier 325%QL 30.6/30dNot coveredNot coveredNot coveredNot coveredTier 317%QL 10.2/30dTier 318%QL 30.6/30dTier 3$45.00QL 30.6/30dNot coveredTier 315%QL 10.2/30dNot covered
budesonide-formoterolgeneric SymbicortNot coveredNot coveredTier 317%QL 30.6/30dNot coveredTier 319%QL 10.2/30dNot coveredNot coveredNot coveredNot coveredNot coveredTier 3$30.00QL 30.6/30d
Advairfluticasone/salmeterolNot coveredTier 325%QL 12/30dTier 317%QL 12/30dTier 325%QL 12/30dNot coveredNot coveredNot coveredNot coveredTier 321%QL 12/30dNot coveredTier 3$30.00QL 12/30d
Wixela Inhubfluticasone/salmeterol, generic AdvairNot coveredNot coveredTier 317%QL 60/30dNot coveredTier 2$10.00QL 60/30dTier 317%QL 60/30dNot coveredNot coveredNot coveredTier 315%QL 60/30dTier 3$30.00QL 60/30d
Duleramometasone/formoterolNot coveredNot coveredTier 432%QL 39/30dNot coveredTier 435%QL 13/30dTier 435%QL 13/30dNot coveredNot coveredNot coveredTier 430%QL 13/30dTier 435%QL 39/30d
Arnuity Elliptafluticasone furoateTier 325%QL 30/30dTier 325%QL 30/30dTier 317%QL 30/30dTier 325%QL 30/30dTier 319%QL 30/30dNot coveredTier 318%QL 30/30dTier 3$45.00QL 30/30dTier 321%QL 30/30dTier 315%QL 30/30dTier 3$30.00QL 30/30d

Where a plan covers several strengths or forms of a drug, the cell shows the least restricted one. Costs are the 30-day preferred-pharmacy cost-sharing in the initial coverage phase, from the CMS 2026 formulary files. Click a plan for its full drug list.